Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that Anthony S. Marucci, President and Chief Executive Officer of Celldex Therapeutics, Inc., will present at the following investor conferences:
- Jefferies 2010 Global Life Sciences Conference on Tuesday, June 8, 2010 at 3:00 pm ET
- 9th Annual Needham Healthcare Conference on Wednesday, June 9, 2010 at 9:20 am ET
A live webcast of the audio and slide presentation from the Jefferies event will be available online on the “Presentations” page of the “Investors” section of the Celldex website at http://www.celldextherapeutics.com and will be archived for 30 days following the event.
About Celldex Therapeutics, Inc.
Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators used in optimal combinations to create novel disease-specific drug candidates. For more information, please visit http://www.celldextherapeutics.com.
Contacts:
Anthony S. Marucci, 781-433-0771
President
and CEO
or
Celldex Therapeutics, Inc.
Avery W. Catlin,
781-433-0771
Chief Financial Officer
IR@celldextherapeutics.com
or
Celldex
Investor Relations:
MacDougall Biomedical Communications
Sarah
Cavanaugh, 781-235-3060
scavanaugh@macbiocom.com
or
Celldex
Media:
BMC Communications Group
Matthew Driscoll,
212-477-9007 x20
mdriscoll@bmccommunications.com